Redefining micrometastasis in prostate cancer - A comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 896-904

  Murray, N P ^a,b,c   Reyes, E ^a   Tapia, P ^d   Badinez, L ^e   Orellana, N ^a   Fuentealba, C ^a   Olivares, R ^a   Porcell, J ^a   Duenas R ^a  

^a Department of Oral and Maxillofacial Surgery   (Chile)

^b UNIVERSIDAD MAYOR   (Chile)

^c Institute of Bio Oncology   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^e Instituto Oncológico Fundación Arturo López Pérez   (Chile)

Author keywords

Bone marrow; Circulating prostate cells; Disseminated tumor cells; Micrometastasis; Prostate cancer

Indexed keywords

GELATINASE A;

ARTICLE; BLOOD; BONE MARROW; BONE MARROW BIOPSY; CANCER INFILTRATION; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; MALE; MICROMETASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; TREATMENT FAILURE; TUMOR CELL;

AGED; AGED, 80 AND OVER; BONE MARROW; BONE MARROW NEOPLASMS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM MICROMETASTASIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84866520971     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1071     Document Type: Article

References (26)

1. NCCN prostate cancer guidelines 2012. Accessed www.nccn2012.org.
2. Freedland SJ, Sutter ME, Dorey F and Aronson WJ: Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy: prostate specific antigen. Urology 61: 365-369, 2003. (Pubitemid 36206534)
3. Wood DP and Banerjee M: Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol 15: 3451-3457, 1997.
4. Cher ML, De Oliveira JG, Beaman AA, Nemeth JA, Hussain M and Wood DP Jr: Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer. Clin Cancer Res 5: 2421-2425, 1999. (Pubitemid 29437322)
5. Oberneder R, Riesenberg R, Kreigmair M, et al: Immunocytochemical detection and phenotypic characterization of micrometastatic tumor cells in bone marrow of patients with prostate cancer. Urol Res 22: 3-8, 1994. (Pubitemid 24149213)
6. Pantel K, Aignherr C, Kollermann J, Caprano J, Riethmuller G and Kollermann MW: Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated stage C prostate cancer. Eur J Cancer 31: A1627-A1632, 1995.
7. Murray NP, Calaf GM and Badinez L: Presence of prostate cells in bone marrow biopsies as a sign of micrometastasis in cancer patients. Oncol Rep 21: 571-575, 2009.
8. Bearden JD, Ratkin GA and Coltman CA: Comparison of the diagnostic value of bone marrow biopsy and bone marrow aspiration in neoplastic disease. J Clin Pathol 27: 738-740, 1972.
9. Bjorneklett A, Slavern P and Elgio K: Relative value of sterna aspiration, iliac crest biopsy and biopsy imprint in the diagnosis of secondary cancer involvement of the bone marrow. Acta Med Scand 203: 279-281, 1978. (Pubitemid 8323239)
10. Moid F and DePalma L: Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma. Arch Pathol Lab Med 129: 497-501, 2005. (Pubitemid 40471196)
11. Borgen E, Naume B, Nesland JM, Kvalhein E, Beiske K, Fodsted O, et al: Standardization of the immunocytochemical detection of cancer cells in bone marrow and blood: I. establishment of objec tive criteria for the evaluation of immunostained cells. Cytotherapy 5: 377-388, 1999.
12. Trudel D, Fradet Y, Meyer F, Harel F and Tetu B: Significance of MMP-2 expression in prostate cancer. Cancer Res 63: 8511-8515, 2003.
13. Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, et al: HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer. Clin Cancer Res 7: 2643-2647, 2001. (Pubitemid 32911366)
14. Askenasy N and Farkas DL: Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo. Stem Cells 20: 501-513, 2002. (Pubitemid 35463063)
15. Quesenberry PJ and Becker PS: Stem cell homing: rolling, crawling and nesting. Proc Natl Acad Sci USA 95: 15155-15157, 1998. (Pubitemid 29018665)
16. Christensen JL, Wright DE, Wagers AJ and Weissman IL: Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol 2: E75, 2004.
17. Mazo IB and Von Andrian UH: Adhesion and homing of blood-borne cells in bone marrow microvessels. J Leukoc Biol 66: 25-32, 1999. (Pubitemid 29321366)
18. Murray NP, Badínez L, Badínez O, Orellana N, Dueñas R, Reyes E and Fuentealba C: Expresión del supresor tumoral CD82 en células prostáticas primarias y secundarias en la circulación sanguínea (CPCs) de pacientes con cáncer prostático. Rev Mex Urol 70: 92-96, 2010 (In Spanish).
19. Murray NP, Badinez L, Dueñas R, Orellana N and Tapia P: Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol. Indian J Urol 27: 200-207, 2011.
20. Chung LW, Baseman A, Assikis V and Zhau HE: Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 173: 10-20, 2005. (Pubitemid 39627663)
21. Sato T, Sakai T, Noguvhi Y, Takita M, Hirakawa S and Ito A: Tumor stromal cell contact promotes invasion of human cervical carcinoma cells by augmenting the expression and activation matrix metalloproteinases. Gynecol Oncol 92: 47-56, 2004. (Pubitemid 38147370)
22. Heissig B, Ohki Y, Sato Y, Rafii S, Werb Z, and Hattori K: A role for niches in hematopoietic cell development. Hematology 10: 247-253, 2005. (Pubitemid 41801141)
23. Yaniv I, Stein J, Farkas DL and Ashenasy N: The tale of early hematopoietic cell seeding in the bone marrow niche. Stem Cells Dev 15: 4-16, 2006.
24. Kaplan RN, Psaila B and Lyden D: Niche to niche migration of bone marrow derived cells. Trends Mol Med 13: 72-81, 2007.
25. Taichmann RS: Blood and bone: two tissues whose fates are intertwined to create the hematopoietic cell stem niche. Blood 105: 2631-2639, 2005.
26. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744, 2000.